Psoriasis injection okayed for limited use to treat COVID patients: Drug controller
Team Udayavani, Jul 11, 2020, 8:11 AM IST
Image for representation
New Delhi: India’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for ‘restricted emergency use’ to treat COVID-19 patients with moderate to severe acute respiratory distress, officials told PTI on Friday.
Considering the unmet medical needs to treat COVID-19, Drugs Controller General of India, Dr V G Somani, approved monoclonal antibody injection Itolizumab, an already approved drug of Biocon, for restricted emergency use for the treatment of ‘cytokine’ release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19, they said.
‘The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by the expert committee comprising pulmonologists, pharmacologists and medicine experts from AIIMS, among others, for treatment of cytokine release syndrome,” an official told PTI.
‘It is already an approved drug of Biocon for treating psoriasis for last many years,’ the official said.
Written informed consent of each patient is required before the use of this drug, he said.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Covid-19 vaccination: Karnataka reports 463 adverse events
K’taka COVID-19 update: 501 new cases, 665 discharges, 4 deaths on Jan 19
US couple celebrates 73rd wedding anniversary with vaccinations
47% of designated beneficiaries vaccinated on Jan 19 in Karnataka
K’taka COVID-19 update: 645 new cases, 807 discharges, 6 deaths on Jan 18
MUST WATCH
Latest Additions
Health minister assures people on safety, efficacy of COVID vaccines
Boy set ablaze by father for delay over getting beedis dies
Man arrested for smuggling gold concealed in rectum at MIA
Actress Shruti visits Majestic bus stand to view implementation of KSRTC’s Sthree toilet
UP police drops charges against Karnataka man under anti-conversion law